X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES SUN PHARMA JUBILANT LIFE SCIENCES/
SUN PHARMA
 
P/E (TTM) x 15.4 42.4 36.3% View Chart
P/BV x 4.5 3.3 138.2% View Chart
Dividend Yield % 0.4 0.4 104.2%  

Financials

 JUBILANT LIFE SCIENCES   SUN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
SUN PHARMA
Mar-18
JUBILANT LIFE SCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs187701 26.7%   
Low Rs65433 15.0%   
Sales per share (Unadj.) Rs364.3110.4 330.0%  
Earnings per share (Unadj.) Rs6.811.0 62.4%  
Cash flow per share (Unadj.) Rs24.517.2 142.2%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %2.40.4 675.1%  
Book value per share (Unadj.) Rs164.9158.8 103.8%  
Shares outstanding (eoy) m159.282,399.26 6.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.35.1 6.7%   
Avg P/E ratio x18.451.6 35.6%  
P/CF ratio (eoy) x5.132.9 15.6%  
Price / Book Value ratio x0.83.6 21.4%  
Dividend payout %43.818.2 240.5%   
Avg Mkt Cap Rs m20,0611,360,021 1.5%   
No. of employees `0006.217.8 34.8%   
Total wages/salary Rs m11,05253,671 20.6%   
Avg. sales/employee Rs Th9,383.014,890.9 63.0%   
Avg. wages/employee Rs Th1,786.93,017.1 59.2%   
Avg. net profit/employee Rs Th176.31,480.6 11.9%   
INCOME DATA
Net Sales Rs m58,034264,895 21.9%  
Other income Rs m1918,388 2.3%   
Total revenues Rs m58,224273,282 21.3%   
Gross profit Rs m5,78656,081 10.3%  
Depreciation Rs m2,81214,998 18.7%   
Interest Rs m3,2375,176 62.5%   
Profit before tax Rs m-7244,295 -0.2%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-9,505 -22.6%   
Tax Rs m6968,452 8.2%   
Profit after tax Rs m1,09026,338 4.1%  
Gross profit margin %10.021.2 47.1%  
Effective tax rate %-965.919.1 -5,062.0%   
Net profit margin %1.99.9 18.9%  
BALANCE SHEET DATA
Current assets Rs m29,280316,359 9.3%   
Current liabilities Rs m38,912198,643 19.6%   
Net working cap to sales %-16.644.4 -37.3%  
Current ratio x0.81.6 47.2%  
Inventory Days Days8495 89.0%  
Debtors Days Days51108 47.1%  
Net fixed assets Rs m55,712213,178 26.1%   
Share capital Rs m1552,399 6.4%   
"Free" reserves Rs m20,968378,606 5.5%   
Net worth Rs m26,265381,006 6.9%   
Long term debt Rs m17,16917,721 96.9%   
Total assets Rs m88,606643,028 13.8%  
Interest coverage x1.09.6 10.2%   
Debt to equity ratio x0.70 1,405.4%  
Sales to assets ratio x0.70.4 159.0%   
Return on assets %4.94.9 99.7%  
Return on equity %4.26.9 60.1%  
Return on capital %11.610.0 115.4%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00440,816 53.9%   
Fx outflow Rs m11,74930,143 39.0%   
Net fx Rs m10,25510,673 96.1%   
CASH FLOW
From Operations Rs m8,02639,072 20.5%  
From Investments Rs m-1,744-33,708 5.2%  
From Financial Activity Rs m-4,447-15,393 28.9%  
Net Cashflow Rs m1,834-7,359 -24.9%  

Share Holding

Indian Promoters % 45.6 63.7 71.6%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 5.1 169.6%  
FIIs % 21.2 23.0 92.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 8.3 254.2%  
Shareholders   23,815 133,026 17.9%  
Pledged promoter(s) holding % 15.9 0.5 2,990.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   TORRENT PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

The BSE HEALTHCARE Index Down 2% ; LINCOLN PHAR Among Top Losers (Market Updates)

Nov 14, 2018 | Updated on Nov 14, 2018

The BSE HEALTHCARE Index Down at 14,508 (down 2.0%). Among the top losers in the BSE HEALTHCARE Index today are LINCOLN PHAR, SUN PHARMA and NOVARTIS. Meanwhile, the BSE Sensex has plunged 0.3% to 35,352.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

PAGE INDUSTRIES Plunges by 5%; BSE 500 Index Flat (Market Updates)

Nov 14, 2018 | Updated on Nov 14, 2018

PAGE INDUSTRIES share price has plunged by 5% and its current market price is Rs 29,260. The BSE 500 is down by 0.0%. The top gainers in the BSE 500 Index are TATA INVEST. CORP. (up 13.6%) and INTERGLOBE AVIATION (INDIGO) (up 6.7%). The top losers are PAGE INDUSTRIES (down 5.0%) and SUN PHARMA (down 7.1%).

INFIBEAM AVENUES Plunges by 6%; BSE 500 Index Up 0.1% (Market Updates)

Nov 14, 2018 | Updated on Nov 14, 2018

INFIBEAM AVENUES share price has plunged by 6% and its current market price is Rs 58. The BSE 500 is up by 0.1%. The top gainers in the BSE 500 Index are TATA INVEST. CORP. (up 13.5%) and INTERGLOBE AVIATION (INDIGO) (up 6.6%). The top losers are INFIBEAM AVENUES (down 6.1%) and SUN PHARMA (down 7.2%).

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Nov 14, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS